NASDAQ
CNS Pharmaceuticals, Inc. (CNSP) has a current ratio of 1.98x as of Monday, May 25, 2026. This represents a 18.89% decrease compared to its 12-month average of 2.44x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.